EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D Deficiency and the Clinical Outcomes of Calcimimetic Therapy in Dialysis Patients: A Population-Based Study

Kuo-Cheng Lu, Joshua Wang, Cai-Mei Zheng iD, Kuo-Wang Tsai, Yi-Chou Hou, Chien-Lin Lu

Nutrients · 2025

DOI: 10.3390/nu17091536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Kuo-Cheng Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan. Hauptthemen laut MEDLINE: Renal Dialysis, Vitamin D Deficiency, Calcimimetic Agents, Hyperparathyroidism, Secondary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fu Jen Catholic University Hospital, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitamin D deficiency (VDD) is prevalent in patients with secondary hyperparathyroidism (SHPT) undergoing dialysis and may attenuate the efficacy of calcimimetic therapy, which is designed to reduce parathyroid hormone (PTH) levels and improve clinical outcomes. This study aimed to investigate the impact of vitamin D status on all-cause mortality, major adverse cardiovascular events (MACEs), fractures, and hypocalcemia in dialysis patients receiving calcimimetics.

Methods

This retrospective cohort study utilized the TriNetX database to identify dialysis patients treated with calcimimetics between 2010 and 2024. Patients were classified into VDD (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisVitamin D DeficiencyCalcimimetic AgentsHyperparathyroidism, SecondaryHumansFemaleMaleRetrospective StudiesMiddle AgedAgedParathyroid HormoneHypocalcemiaVitamin DTreatment OutcomeCardiovascular DiseasesFractures, Bone

Stichwörter der Autor:innen

calcimimetic therapycardiovascular eventsfracture risksecondary hyperparathyroidismvitamin D deficiency

Substanzen

Calcimimetic AgentsParathyroid HormoneVitamin D

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
  • Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
  • School of Biomedical Sciences, Queensland University of Technology, Brisbane 4001, Australia.
  • Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, School of Medicine, College of Medicine, Taipei Medical University, New Taipei City 11031, Taiwan.
  • TMU Research Centre of Urology and Kidney, Taipei Medical University, New Taipei City 11031, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Cardinal-Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.

ORCID-Profile: Cai-Mei Zheng

Förderung

  • Fu Jen Catholic University Hospital
  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Zitieren

APA

Lu, K. C., Wang, J., Zheng, C. M., Tsai, K. W., Hou, Y. C., & Lu, C. L. (2025). Vitamin D Deficiency and the Clinical Outcomes of Calcimimetic Therapy in Dialysis Patients: A Population-Based Study. Nutrients. https://doi.org/10.3390/nu17091536

Vancouver

Lu KC, Wang J, Zheng CM, Tsai KW, Hou YC, Lu CL. Vitamin D Deficiency and the Clinical Outcomes of Calcimimetic Therapy in Dialysis Patients: A Population-Based Study. Nutrients. 2025. doi:10.3390/nu17091536

BibTeX
@article{Lu2025,
  author = {Lu, Kuo-Cheng and Wang, Joshua and Zheng, Cai-Mei and Tsai, Kuo-Wang and Hou, Yi-Chou and Lu, Chien-Lin},
  title = {Vitamin D Deficiency and the Clinical Outcomes of Calcimimetic Therapy in Dialysis Patients: A Population-Based Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091536}
}
Kostenlos starten →